Sequential therapy with bevacizumab and EGFR inhibitors for metastatic colorectal carcinoma: a national registry-based analysis

Sequential therapy with bevacizumab and EGFR inhibitors for metastatic colorectal carcinoma: a national registry-based analysis

Tomas Buchler,1 Renata Chloupkova,2 Alexandr Poprach,3 Ondrej Fiala,4,5 Igor Kiss,3 Katerina Kopeckova,6 Ladislav Dusek,2 Veronika Veskrnova,1 Lubomir Slavicek,7 Milan Kohoutek,8 Jindrich Finek,4 Marek Svoboda,3 Lubos Petruzelka,9 Bohuslav Melichar10 1Department of Oncology, First Faculty of Medicin...

Full description

Bibliographic Details
Main Authors: Buchler T, Chloupkova R, Poprach A, Fiala O, Kiss I, Kopeckova K, Dusek L, Veskrnova V, Slavicek L, Kohoutek M, Finek J, Svoboda M, Petruzelka L, Melichar B
Format: Article
Language:English
Published: Dove Medical Press 2018-12-01
Series:Cancer Management and Research
Subjects:
colorectal carcinoma
bevacizumab
panitumumab
cetuximab
sequence
Online Access:https://www.dovepress.com/sequential-therapy-with-bevacizumab-and-egfr-inhibitors-for-metastatic-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/sequential-therapy-with-bevacizumab-and-egfr-inhibitors-for-metastatic-peer-reviewed-article-CMAR

Similar Items